These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16211354)

  • 1. No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell lines.
    Shao RX; Otsuka M; Kato N; Chang JH; Muroyama R; Taniguchi H; Moriyama M; Wang Y; Kawabe T; Omata M
    J Gastroenterol; 2005 Sep; 40(9):918. PubMed ID: 16211354
    [No Abstract]   [Full Text] [Related]  

  • 2. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
    Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
    Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.
    Kubo T; Kuroda Y; Kokubu A; Hosoda F; Arai Y; Hiraoka N; Hirohashi S; Shibata T
    Pancreas; 2009 Oct; 38(7):e200-6. PubMed ID: 19893451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of hepatic micrometastasis in ductal pancreatic carcinoma by K-ras mutation analysis and determination of clinical relevance].
    Bastian D; Gerdes B; Ramaswamy A; Tschammer C; Bartsch D
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):45-7. PubMed ID: 14518210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma.
    Chuah BY; Yeo WL; Guo JY; Lim SG; Yap HL; Goh BC; Lee SC
    Acta Oncol; 2009; 48(4):628-30. PubMed ID: 19160077
    [No Abstract]   [Full Text] [Related]  

  • 6. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
    Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
    Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer.
    Iwase T; Tanaka M; Suzuki M; Naito Y; Sugimura H; Kino I
    Biochem Biophys Res Commun; 1993 Jul; 194(2):698-705. PubMed ID: 7688222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors.
    Moser C; Lang SA; Hackl C; Zhang H; Lundgren K; Hong V; McKenzie A; Weber B; Park JS; Schlitt HJ; Geissler EK; Jung YD; Stoeltzing O
    Anticancer Res; 2012 Feb; 32(2):427-37. PubMed ID: 22287729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.
    Han HJ; Yanagisawa A; Kato Y; Park JG; Nakamura Y
    Cancer Res; 1993 Nov; 53(21):5087-9. PubMed ID: 8221640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
    Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
    Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning.
    Shibata-Minoshima F; Oki T; Doki N; Nakahara F; Kageyama S; Kitaura J; Fukuoka J; Kitamura T
    Int J Oncol; 2012 Jan; 40(1):93-8. PubMed ID: 21874235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Fyn in pancreatic cancer metastasis.
    Chen ZY; Cai L; Bie P; Wang SG; Jiang Y; Dong JH; Li XW
    J Gastroenterol Hepatol; 2010 Feb; 25(2):293-301. PubMed ID: 19968749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinases and gastric cancer.
    Lin W; Kao HW; Robinson D; Kung HJ; Wu CW; Chen HC
    Oncogene; 2000 Nov; 19(49):5680-9. PubMed ID: 11114748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase domain mutation of MLK4 gene is uncommon in gastric and hepatocellular carcinomas.
    Soung YH; Lee JW; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Dig Liver Dis; 2006 Apr; 38(4):283. PubMed ID: 16309983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alterations in DPC4 gene in pancreatic cancers].
    Gu L; Chen J; Cui Q
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a.
    Guo B; Liu L; Yao J; Ma R; Chang D; Li Z; Song T; Huang C
    Mol Cancer Res; 2014 Mar; 12(3):313-21. PubMed ID: 24375644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.